Count | |
| 2 | |
| 2 | |
| 11 | |
| 2 | |
| 2 | |
| 2 | |
| 1 | |
| 5 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 15 | |
| 1 | |
| 1 | |
| 1 | |
| 100 | |
| 1 | |
| 10 | |
Adenosine Monophosphate/*analogs & derivatives/*pharmacology | 1 |
| 1 | |
8-Bromo Cyclic Adenosine Monophosphate/metabolism/pharmacology | 2 |
8-Bromo Cyclic Adenosine Monophosphate/*analogs & derivatives/metabolism | 1 |
8-Bromo Cyclic Adenosine Monophosphate/*analogs & derivatives/toxicity | 1 |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
Adenosine/administration & dosage/*diagnostic use/pharmacology | 1 |
| 1 | |
| 3 | |
| 1 | |
| 2 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Thymidine Monophosphate/*antagonists & inhibitors/biosynthesis | 1 |
| 1 | |
| 3 | |
Inosine Monophosphate/*analogs & derivatives/pharmacology/therapeutic use | 1 |
Deoxycytidine Monophosphate/*analogs & derivatives/chemistry/metabolism | 1 |
| 2 | |
| 7 | |
| 1 | |
| 25 | |
| 16 | |
| 2 | |
| 1 | |
| 1 | |
| 5 | |
| 1 | |
| 3 | |
| 1 | |
| 4 | |
| 1 | |
| 10 | |
| 1 | |
| 4 | |
| 5 | |
| 10 | |
| 3 | |
| 1 | |
| 3 | |
| 1 | |
| 11 | |
| 3 | |
| 1 | |
| 1 | |
| 12 | |
| 1 | |
| 114 | |
| 28 | |
| 1 | |
| 11 | |
| 8 | |
| 3 | |
| 2 | |
| 1 | |
| 4 | |
| 4 | |
| 8 | |
| 68 | |
| 2 | |
| 2 | |
| 1 | |
| 2 | |
| 2 | |